|
Valoración de DCF de Lantheus Holdings, Inc. (LNTH)
US | Healthcare | Drug Manufacturers - Specialty & Generic | NASDAQ
|
- ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
- ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
- ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
- ✓ No Se Necesita Experiencia; Fáciles De Seguir
Lantheus Holdings, Inc. (LNTH) Bundle
¡Ahorre tiempo y mejore la precisión con nuestra calculadora DCF (LNTH)! Utilizando datos reales de Lantheus Holdings, Inc. y supuestos personalizables, esta herramienta le permite pronosticar, analizar y valorar a Lantheus como un inversor experimentado.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 347.3 | 339.4 | 425.2 | 935.1 | 1,296.4 | 1,276.2 | 1,256.3 | 1,236.6 | 1,217.3 | 1,198.3 |
| Revenue Growth, % | 0 | -2.28 | 25.28 | 119.91 | 38.65 | -1.56 | -1.56 | -1.56 | -1.56 | -1.56 |
| EBITDA | 55.6 | 22.7 | -25.0 | 81.8 | 491.0 | 161.9 | 159.4 | 156.9 | 154.5 | 152.1 |
| EBITDA, % | 16.01 | 6.68 | -5.88 | 8.75 | 37.87 | 12.69 | 12.69 | 12.69 | 12.69 | 12.69 |
| Depreciation | 13.4 | 24.7 | 42.3 | 47.9 | 60.0 | 78.7 | 77.5 | 76.2 | 75.1 | 73.9 |
| Depreciation, % | 3.85 | 7.27 | 9.95 | 5.13 | 4.63 | 6.17 | 6.17 | 6.17 | 6.17 | 6.17 |
| EBIT | 42.2 | -2.0 | -67.3 | 33.9 | 431.0 | 83.3 | 82.0 | 80.7 | 79.4 | 78.2 |
| EBIT, % | 12.16 | -0.58926 | -15.82 | 3.63 | 33.24 | 6.52 | 6.52 | 6.52 | 6.52 | 6.52 |
| Total Cash | 92.9 | 79.6 | 98.5 | 415.7 | 713.7 | 441.2 | 434.4 | 427.6 | 420.9 | 414.3 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 43.5 | 54.0 | 89.3 | 213.4 | 284.3 | 240.4 | 236.7 | 233.0 | 229.4 | 225.8 |
| Account Receivables, % | 12.53 | 15.91 | 21.01 | 22.82 | 21.93 | 18.84 | 18.84 | 18.84 | 18.84 | 18.84 |
| Inventories | 29.2 | 35.7 | 35.1 | 35.5 | 64.0 | 91.7 | 90.3 | 88.9 | 87.5 | 86.1 |
| Inventories, % | 8.4 | 10.53 | 8.26 | 3.79 | 4.94 | 7.19 | 7.19 | 7.19 | 7.19 | 7.19 |
| Accounts Payable | 18.6 | 16.3 | 20.8 | 20.6 | 41.2 | 52.1 | 51.3 | 50.5 | 49.7 | 48.9 |
| Accounts Payable, % | 5.36 | 4.8 | 4.89 | 2.2 | 3.18 | 4.08 | 4.08 | 4.08 | 4.08 | 4.08 |
| Capital Expenditure | -22.1 | -12.5 | -12.1 | -18.3 | -46.6 | -47.1 | -46.3 | -45.6 | -44.9 | -44.2 |
| Capital Expenditure, % | -6.35 | -3.68 | -2.86 | -1.96 | -3.59 | -3.69 | -3.69 | -3.69 | -3.69 | -3.69 |
| Tax Rate, % | 20.51 | 20.51 | 20.51 | 20.51 | 20.51 | 20.51 | 20.51 | 20.51 | 20.51 | 20.51 |
| EBITAT | 46.7 | -2.3 | -63.9 | 35.6 | 342.6 | 79.0 | 77.8 | 76.6 | 75.4 | 74.2 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -16.1 | -9.5 | -64.0 | -59.4 | 277.2 | 137.7 | 113.3 | 111.5 | 109.8 | 108.1 |
| WACC, % | 6.66 | 6.66 | 6.64 | 6.66 | 6.58 | 6.64 | 6.64 | 6.64 | 6.64 | 6.64 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 484.0 | |||||||||
| Long Term Growth Rate, % | 4.00 | |||||||||
| Free cash flow (T + 1) | 112 | |||||||||
| Terminal Value | 4,263 | |||||||||
| Present Terminal Value | 3,091 | |||||||||
| Enterprise Value | 3,575 | |||||||||
| Net Debt | -97 | |||||||||
| Equity Value | 3,672 | |||||||||
| Diluted Shares Outstanding, MM | 70 | |||||||||
| Equity Value Per Share | 52.28 |
What You Will Receive
- Comprehensive Financial Model: Lantheus Holdings, Inc.'s (LNTH) actual data facilitates accurate DCF valuation.
- Complete Forecast Customization: Modify revenue growth, profit margins, WACC, and other crucial metrics.
- Real-Time Calculations: Automatic updates provide immediate feedback as you adjust inputs.
- Professional-Grade Template: A polished Excel file crafted for high-quality valuation analysis.
- Flexible and Reusable: Designed for adaptability, allowing for repeated use in detailed forecasting.
Key Features
- Real-Life LNTH Data: Pre-filled with Lantheus Holdings’ historical financials and forward-looking projections.
- Fully Customizable Inputs: Adjust revenue growth, margins, WACC, tax rates, and capital expenditures.
- Dynamic Valuation Model: Automatic updates to Net Present Value (NPV) and intrinsic value based on your inputs.
- Scenario Testing: Create multiple forecast scenarios to analyze different valuation outcomes.
- User-Friendly Design: Simple, structured, and designed for professionals and beginners alike.
How It Works
- Download the Template: Gain immediate access to the Excel-based LNTH DCF Calculator.
- Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and other variables.
- Instant Calculations: The model automatically recalculates Lantheus Holdings’ intrinsic value.
- Test Scenarios: Experiment with various assumptions to assess potential changes in valuation.
- Analyze and Decide: Utilize the findings to inform your investment or financial analysis decisions.
Why Choose This Calculator for Lantheus Holdings, Inc. (LNTH)?
- Accuracy: Utilizes real Lantheus financial data for precise calculations.
- Flexibility: Allows users to easily adjust and test various inputs.
- Time-Saving: Eliminate the need to create a DCF model from the ground up.
- Professional-Grade: Crafted with the expertise and standards of CFOs in mind.
- User-Friendly: Intuitive design makes it accessible for users with limited financial modeling knowledge.
Who Should Use This Product?
- Healthcare Investors: Develop comprehensive valuation models for analyzing Lantheus Holdings, Inc. (LNTH) in the biotech sector.
- Corporate Finance Teams: Evaluate valuation scenarios to inform strategic decisions within the healthcare industry.
- Consultants and Advisors: Deliver precise valuation insights for clients interested in Lantheus Holdings, Inc. (LNTH).
- Students and Educators: Utilize real-world data to enhance learning and practice in financial modeling related to the biotech field.
- Biotech Enthusiasts: Gain insights into how companies like Lantheus Holdings, Inc. (LNTH) are valued in the market.
What the Template Contains
- Preloaded LNTH Data: Historical and projected financial data, including revenue, EBIT, and capital expenditures.
- DCF and WACC Models: Professional-grade sheets for calculating intrinsic value and Weighted Average Cost of Capital.
- Editable Inputs: Yellow-highlighted cells for adjusting revenue growth, tax rates, and discount rates.
- Financial Statements: Comprehensive annual and quarterly financials for deeper analysis.
- Key Ratios: Profitability, leverage, and efficiency ratios to evaluate performance.
- Dashboard and Charts: Visual summaries of valuation outcomes and assumptions.